Suscribirse

Routine coronary arteriography before abdominal aortic aneurysm repair - 12/09/11

Doi : 10.1016/S0002-9610(05)80008-X 
Murat Bayazit, MD , M. Kamil Göl, MD, Bektas Battaloglu, MD, Hilmi Tokmakoglu, MD, Oguz Tasdemir, MD, Kemal Bayazit, MD
 From Türkiye Yüksek Ihtisas Hastanesi, Cardiovascular Surgery Clinic, Ankara, Turkey 

1Requests for reprints should be addressed to Murat Bayazit, MD, Türkiye Yüksek Ihtisas Hastanesi, Kalp ve Damar Cerrahisi Klinigi, Sihhiyi 06100, Ankara, Turkey.

Abstract

Background:

As cardiac complications constitute the principal cause of early and late morbidity and mortality after the surgical treatment of abdominal aortic aneurysm (AAA), a prospective study was planned to evaluate the effects of revascularization of coronary arteries on survival after AAA repair during early and long-term follow-up periods.

Patients and Methods:

A total of 125 patients underwent elective repair of AAA between 1986 and 1994. Coronary arteriography was performed in all cases. All cases with critical left anterior descending artery (LAD) lesions underwent a coronary artery bypass operation either simultaneously or shortly before AAA repair. In addition, percutaneous transluminal coronary angioplasty (PTCA) was performed for symptomatic and critical stenosis of arteries other than the LADs, or if noncritical but symptomatic stenosis of the LADs existed. Early and late follow-up data were obtained for all cases, and late-term cumulative survival rates were calculated.

Results:

Coronary artery lesions were found in 66 (53%) cases. In 24 cases, AAA repairs were performed 2.3 (mean) months after coronary artery bypass grafting (CABG), whereas in 4 cases both procedures were performed simultaneously. PTCA was performed in 4 cases 3 to 4 days prior to the abdominal surgery. Even though the coronary artery lesions were found inoperable in 7 cases, these patients underwent repair of AAA because of rapidly expanding and painful aneurysms. Early mortality rate was 4% (5 cases), in which 3 of these were from the group inoperable for CABG. A mean follow-up of 3.17 years (3 to 87 months) was achieved for all discharged patients. Cumulative survival rates for 6 months and 1, 2, 3, and 6 years were 99%, 99%, 95%, 93%, and 89%, respectively.

Conclusions:

The results of this study emphasize the importance of coronary artery revascularization for early, and especially for late, survival after AAA repair.

El texto completo de este artículo está disponible en PDF.

© 1995  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 170 - N° 3

P. 246-250 - septembre 1995 Regresar al número
Artículo precedente Artículo precedente
  • Breast cancer in young patients
  • Joaquin Sariego, Steven Zrada, Michael Byrd, Teruo Matsumoto
| Artículo siguiente Artículo siguiente
  • Autologous saphenous vein popliteal-tibial artery bypass for limb-threatening ischemia: A reassessment
  • Jeffrey L. Ballard, J. David Killen, T.J. Bunt, James M. Malone

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.